GLP-1RA therapy persistence was evaluated using 2 approaches
Others feel consistent suppression throughout the week
According to patient data, adult patients with Type 2 diabetes were 2.56 times more likely to develop NAION within one year after starting a GLP-1 product than those who started a dipeptidyl peptidase 4 inhibitor
With Wegovy, studies show an average of 15% body weight reduction over 68 weeks
Were going to see them approved for other things, like weve seen for semaglutide with cardiovascular approval, said Fitch, pointing specifically to sleep apnea and fatty liver disease
Serve over baby spinach with diced cucumber, cherry tomatoes, red onion, feta cheese, and a lemon-tahini dressing